SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC boosted its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 11.2% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 94,950 shares of the exchange traded fund’s stock after purchasing an additional 9,536 shares during the period. Janney Montgomery Scott LLC owned approximately 0.12% of SPDR S&P Biotech ETF worth $9,010,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Alta Wealth Advisors LLC purchased a new stake in SPDR S&P Biotech ETF during the first quarter worth $450,000. Mirae Asset Global Investments Co. Ltd. raised its position in shares of SPDR S&P Biotech ETF by 15.2% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 29,320 shares of the exchange traded fund’s stock worth $2,782,000 after acquiring an additional 3,860 shares during the period. Sequoia Financial Advisors LLC boosted its stake in shares of SPDR S&P Biotech ETF by 14.1% during the 1st quarter. Sequoia Financial Advisors LLC now owns 6,810 shares of the exchange traded fund’s stock worth $646,000 after acquiring an additional 842 shares in the last quarter. Private Advisor Group LLC grew its position in shares of SPDR S&P Biotech ETF by 3.0% during the 1st quarter. Private Advisor Group LLC now owns 226,669 shares of the exchange traded fund’s stock valued at $21,509,000 after acquiring an additional 6,551 shares during the period. Finally, J.W. Cole Advisors Inc. grew its position in shares of SPDR S&P Biotech ETF by 2.3% during the 1st quarter. J.W. Cole Advisors Inc. now owns 36,005 shares of the exchange traded fund’s stock valued at $3,417,000 after acquiring an additional 826 shares during the period.

SPDR S&P Biotech ETF Trading Up 1.7 %

NYSEARCA XBI opened at $93.23 on Tuesday. The stock has a market capitalization of $7.11 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. The stock has a 50-day moving average of $90.90 and a 200 day moving average of $91.14. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.